669 related articles for article (PubMed ID: 32763818)
1. Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
Norinder U; Tuck A; Norgren K; Munic Kos V
Biomed Pharmacother; 2020 Oct; 130():110582. PubMed ID: 32763818
[TBL] [Abstract][Full Text] [Related]
2. The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Ballout RA; Sviridov D; Bukrinsky MI; Remaley AT
FASEB J; 2020 Jun; 34(6):7253-7264. PubMed ID: 32367579
[TBL] [Abstract][Full Text] [Related]
3. COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
Lentini G; Cavalluzzi MM; Habtemariam S
Molecules; 2020 Apr; 25(8):. PubMed ID: 32316270
[TBL] [Abstract][Full Text] [Related]
4. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
Juurlink DN
CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
[No Abstract] [Full Text] [Related]
5. Widely available lysosome targeting agents should be considered as potential therapy for COVID-19.
Homolak J; Kodvanj I
Int J Antimicrob Agents; 2020 Aug; 56(2):106044. PubMed ID: 32522674
[TBL] [Abstract][Full Text] [Related]
6. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
[TBL] [Abstract][Full Text] [Related]
7. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
Gates LE; Hamed AA
J Med Internet Res; 2020 Aug; 22(8):e21169. PubMed ID: 32735546
[TBL] [Abstract][Full Text] [Related]
8. Insights from nanomedicine into chloroquine efficacy against COVID-19.
Hu TY; Frieman M; Wolfram J
Nat Nanotechnol; 2020 Apr; 15(4):247-249. PubMed ID: 32203437
[TBL] [Abstract][Full Text] [Related]
9. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.
Gevers S; Kwa MSG; Wijnans E; van Nieuwkoop C
Clin Microbiol Infect; 2020 Sep; 26(9):1276-1277. PubMed ID: 32422406
[No Abstract] [Full Text] [Related]
10. Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19.
Lei ZN; Wu ZX; Dong S; Yang DH; Zhang L; Ke Z; Zou C; Chen ZS
Pharmacol Ther; 2020 Dec; 216():107672. PubMed ID: 32910933
[TBL] [Abstract][Full Text] [Related]
11. Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin.
Derendorf H
Int J Antimicrob Agents; 2020 Jun; 55(6):106007. PubMed ID: 32389720
[TBL] [Abstract][Full Text] [Related]
12. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
[TBL] [Abstract][Full Text] [Related]
14. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
[TBL] [Abstract][Full Text] [Related]
15. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
[TBL] [Abstract][Full Text] [Related]
16. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
Blaess M; Kaiser L; Sauer M; Csuk R; Deigner HP
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668803
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials.
Patil VM; Singhal S; Masand N
Life Sci; 2020 Aug; 254():117775. PubMed ID: 32418894
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19.
Meo SA; Klonoff DC; Akram J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4539-4547. PubMed ID: 32373993
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine and hydroxychloroquine in covid-19.
Ferner RE; Aronson JK
BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
[No Abstract] [Full Text] [Related]
20. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
